This funding opportunity establishes collaborative, multi-disciplinary research centers to conduct translational and clinical research aimed at developing a vaccine for Valley fever (Coccidioidomycosis). The program supports teams working in alignment with NIAID's strategic plan to advance vaccine development, excluding clinical trials under this award.
Eligible applicants include a wide range of U.S. entities such as special district governments, public housing authorities, higher education institutions, tribal governments, nonprofits, small businesses, and for-profit organizations other than small businesses. Specific eligibility details are prov
